A small study published in JAMA (online, Nov. 12, 2020) disappeared almost without a trace. It compared fluvoxamine to placebo for treating COVID patients. The results were surprisingly good. Out of 152 people with COVID -19, 80 took fluvoxamine and 72 took a look-alike placebo pill. Six of those on placebo had serious clinical deterioration, compared to none of those on fluvoxamine.


Is the MOH [Misrad Ha-Briut] already looking day and night into AMOR-18??